164 related articles for article (PubMed ID: 35484984)
1. CCDC106 promotes the proliferation and invasion of ovarian cancer cells by suppressing p21 transcription through a p53-independent pathway.
Zhao N; Wang C; Guo P; Hou J; Yang H; Lan T; Zhou Y; Li J; Bhawal UK; Liu Y
Bioengineered; 2022 Apr; 13(4):10956-10972. PubMed ID: 35484984
[TBL] [Abstract][Full Text] [Related]
2. CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression.
Ning Y; Wang C; Liu X; Du Y; Liu S; Liu K; Zhou J; Zhou C
J Exp Clin Cancer Res; 2019 Mar; 38(1):131. PubMed ID: 30885251
[TBL] [Abstract][Full Text] [Related]
3. CCDC106 promotes non-small cell lung cancer cell proliferation.
Zhang X; Zheng Q; Wang C; Zhou H; Jiang G; Miao Y; Zhang Y; Liu Y; Li Q; Qiu X; Wang E
Oncotarget; 2017 Apr; 8(16):26662-26670. PubMed ID: 28460455
[TBL] [Abstract][Full Text] [Related]
4. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of the novel protein CCDC106 that interacts with p53 and promotes its degradation.
Zhou J; Qiao X; Xiao L; Sun W; Wang L; Li H; Wu Y; Ding X; Hu X; Zhou C; Zhang J
FEBS Lett; 2010 Mar; 584(6):1085-90. PubMed ID: 20159018
[TBL] [Abstract][Full Text] [Related]
6. Rosline promotes p21 expression to inhibit ovarian cancer cell proliferation via p53-independent pathway.
Zhao T; Xiao X; Li L; Wu X; Yuan T
J Obstet Gynaecol Res; 2023 Aug; 49(8):2126-2134. PubMed ID: 37317483
[TBL] [Abstract][Full Text] [Related]
7. BCL7C suppresses ovarian cancer growth by inactivating mutant p53.
Huang C; Hao Q; Shi G; Zhou X; Zhang Y
J Mol Cell Biol; 2021 May; 13(2):141-150. PubMed ID: 33306126
[TBL] [Abstract][Full Text] [Related]
8. RNF144B-mediated p21 degradation regulated by HDAC3 contribute to enhancing ovarian cancer growth and metastasis.
Zhuang H; Zhang Z; Wang W; Qu H
Tissue Cell; 2024 Feb; 86():102277. PubMed ID: 37992458
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-17 promotes normal ovarian cancer cells to cancer stem cells development via suppression of the LKB1-p53-p21/WAF1 pathway.
Liu T; Qin W; Hou L; Huang Y
Tumour Biol; 2015 Mar; 36(3):1881-93. PubMed ID: 25510663
[TBL] [Abstract][Full Text] [Related]
10. VAV1 represses E-cadherin expression through the transactivation of Snail and Slug: a potential mechanism for aberrant epithelial to mesenchymal transition in human epithelial ovarian cancer.
Wakahashi S; Sudo T; Oka N; Ueno S; Yamaguchi S; Fujiwara K; Ohbayashi C; Nishimura R
Transl Res; 2013 Sep; 162(3):181-90. PubMed ID: 23856093
[TBL] [Abstract][Full Text] [Related]
11. Growth arrest in ovarian cancer cells by hTERT inhibition short-hairpin RNA targeting human telomerase reverse transcriptase induces immediate growth inhibition but not necessarily induces apoptosis in ovarian cancer cells.
Luo Y; Yi Y; Yao Z
Cancer Invest; 2009 Dec; 27(10):960-70. PubMed ID: 19909010
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of PADI2 prevents proliferation and epithelial-mesenchymal transition in ovarian cancer through inhibiting JAK2/STAT3 pathway in vitro and in vivo, alone or in combination with Olaparib.
Liu L; Zhang Z; Zhang G; Wang T; Ma Y; Guo W
J Transl Med; 2020 Sep; 18(1):357. PubMed ID: 32951601
[TBL] [Abstract][Full Text] [Related]
13. Fibrillin-1, induced by Aurora-A but inhibited by BRCA2, promotes ovarian cancer metastasis.
Wang Z; Liu Y; Lu L; Yang L; Yin S; Wang Y; Qi Z; Meng J; Zang R; Yang G
Oncotarget; 2015 Mar; 6(9):6670-83. PubMed ID: 25749384
[TBL] [Abstract][Full Text] [Related]
14. lncRNA MIAT Regulates Cell Growth, Migration, and Invasion Through Sponging miR-150-5p in Ovarian Cancer.
Zhou S; Xu A; Song T; Gao F; Sun H; Kong X
Cancer Biother Radiopharm; 2020 Nov; 35(9):650-660. PubMed ID: 32186927
[No Abstract] [Full Text] [Related]
15. WWOX regulates the Elf5/Snail1 pathway to affect epithelial-mesenchymal transition of ovarian carcinoma cells in vitro.
Xu Y; Yan YC; Hu YK; Fang LS; Li Q; Xu J; Yan HC
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1041-1053. PubMed ID: 32096174
[TBL] [Abstract][Full Text] [Related]
16. Association of p21, p21 p27 and p21 p53 status to histological subtypes and prognosis in low-stage epithelial ovarian cancer.
Skirnisdottir I; Seidal T
Cancer Genomics Proteomics; 2013; 10(1):27-34. PubMed ID: 23382584
[TBL] [Abstract][Full Text] [Related]
17. ASF1B enhances migration and invasion of lung cancers cell via regulating the P53-mediated epithelial-mesenchymal transformation (EMT) signaling pathway.
Wang W; Xiao L; Pan D; Hu L
Neoplasma; 2022 Mar; 69(2):361-369. PubMed ID: 35103478
[TBL] [Abstract][Full Text] [Related]
18. CALB1 enhances the interaction between p53 and MDM2, and inhibits the senescence of ovarian cancer cells.
Cao LQ; Wang YN; Liang M; Pan MZ
Mol Med Rep; 2019 Jun; 19(6):5097-5104. PubMed ID: 31059057
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.
Bali A; O'Brien PM; Edwards LS; Sutherland RL; Hacker NF; Henshall SM
Clin Cancer Res; 2004 Aug; 10(15):5168-77. PubMed ID: 15297421
[TBL] [Abstract][Full Text] [Related]
20. Plakoglobin Reduces the in vitro Growth, Migration and Invasion of Ovarian Cancer Cells Expressing N-Cadherin and Mutant p53.
Alaee M; Danesh G; Pasdar M
PLoS One; 2016; 11(5):e0154323. PubMed ID: 27144941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
